Seeing Is Believing
Cymabay Therapeu's activity chart (see below) currently has 172 price targets and 137 ratings on display.
Analysts average stock forecasts to be materialized ratio is 89.23% with an average time for these price targets to be met of 755.13 days.
Most recent stock forecast was given by from WESTPARK on 29-Feb-2024.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 29-Feb-2024
$32.5
$0.02 (0.06%)
2 years 7 months 24 days ago
(29-Feb-2024)
15/16 (93.75%)
$0.31 (0.96%)
489
Buy Since 12-May-2020
$32.5
$0.02 (0.06%)
$12
2 years 8 months 3 days ago
(20-Feb-2024)
3/4 (75%)
$0.3 (0.93%)
384
Buy Since 12-May-2020
$32.5
$0.02 (0.06%)
$25
2 years 8 months 9 days ago
(14-Feb-2024)
8/9 (88.89%)
$0.32 (0.99%)
1093
Buy Since 03-Aug-2020
$32.5
2 years 8 months 9 days ago
(14-Feb-2024)
12/14 (85.71%)
$0.38 (1.18%)
959
Buy Since 05-Jul-2023
$26
2 years 8 months 10 days ago
(13-Feb-2024)
4/4 (100%)
$3.37 (14.89%)
107
What is CBAY (Cymabay Therapeu) average time for price targets to be met?
Which analyst most recently updated their price target on CBAY (Cymabay Therapeu)?
Which analyst has the most public recommendations on CBAY (Cymabay Therapeu)?
Which analyst is the currently most bullish on CBAY (Cymabay Therapeu)?
Which analyst is the currently most reserved on CBAY (Cymabay Therapeu)?